Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Masina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|January 11, 2024
Curative intent therapy for DLBCL in the elderlyAlessandra Tucci, Lorenzo Masina, Stefano Luminari
Hematological Oncology|August 7, 2022
High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the "Omicron wave" of COVID-19 pandemicChiara Cattaneo, Lorenzo Masina, Chiara Pagani, et al.
Annals of Hematology|February 26, 2025
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplantMarco Galli, Lorenzo Masina, Gabriele Magliano, et al.
British Journal of Haematology|November 18, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex diseaseDiego Bertoli, Carlotta Giupponi, Giuseppe Rossi, et al.
Blood Cancer Journal|December 21, 2023
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related PrognosisErika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Frontiers in Oncology|July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|January 11, 2024
Curative intent therapy for DLBCL in the elderlyAlessandra Tucci, Lorenzo Masina, Stefano Luminari
Hematological Oncology|August 7, 2022
High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the "Omicron wave" of COVID-19 pandemicChiara Cattaneo, Lorenzo Masina, Chiara Pagani, et al.
Annals of Hematology|February 26, 2025
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplantMarco Galli, Lorenzo Masina, Gabriele Magliano, et al.
British Journal of Haematology|November 18, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex diseaseDiego Bertoli, Carlotta Giupponi, Giuseppe Rossi, et al.
Blood Cancer Journal|December 21, 2023
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related PrognosisErika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Frontiers in Oncology|July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Pageof 1